Antiplatelet therapies: From aspirin to GPIIb/IIIa-receptor antagonists and beyond

Drug Discovery Today

Volumn 4, Issue 12, 1999, Pages 552-561

  Mousa, Shaker A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[3 [4 (AMINOIMINOMETHYL)PHENYL] 4,5 DIHYDRO 5 ISOXAZOLYL]ACETAMIDO] N [(3,5 DIMETHYL 4 ISOXAZOLYL)SULFONYL]ALANINE; ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIBODY; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; CAFFEINE; CLOPIDOGREL; CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; DAZOXIBEN; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FRADAFIBAN; HIRUDIN; HIRULOG; KETANSERIN; LAMIFIBAN; LEFRADAFIBAN; ORBOFIBAN; PADGEM PROTEIN; PHOSPHODIESTERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN SYNTHASE; RIDOGREL; ROXIFIBAN; SIBRAFIBAN; THROMBIN; THROMBIN INHIBITOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE; TICLOPIDINE; TIROFIBAN; VON WILLEBRAND FACTOR; XEMILOFIBAN;

ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; HUMAN; REVIEW; STROKE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

EID: 0033485864     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01394-X     Document Type: Review

References (43)

1. Ashby, B., Daniel, J.L. and Smith, J.B. (1990) Platelets Health Dis. 4, 1-26
2. Davies, M.J. and Thomas, A.C. (1985) Br. Heart J. 53, 363-373
3. Fitzgerald, D.J. et al. (1986) New Engl. J. Med. 315, 983-989
4. Fuster, V., Steele, P.M. and Chesebro, J.H. (1985) J. Am. Coll. Cardiol. 5, 175B-184B
5. Hamm, C.W. et al. (1987) J. Am. Coll. Cardiol. 10, 998-1004
6. Mousa, S.A. and Bennett, J.S. (1996) Drugs Future 21, 1141-1154
7. Smitherman, T.C. et al. (1981) Am. J. Cardiol 48, 395-402
8. Rubenstein, M.D. et al. (1981) Am. Heart J. 102, 363-367
9. Theroux, P. et al. (1988) New Engl. J. Med. 319, 1105-1111
10. Lewis, H.D. et al. (1983) New Engl. J. Med. 309, 396-403
11. Schwartz, L. et al. (1988) New Engl. J. Med. 318, 1714-1719
12. Antiplatelet Trialists Collaboration (1994) Br. Med. J. 308, 81-106
13. CAPRIE Steering Committee (1996) Lancet 348, 1329-1339
14. CAST (Chinese Acute Stroke Trial) Collaborative group (1997) Lancet 349, 1641-1649
15. Mousa, S. and Reilly, T. (1995) in Cardiovascular Disease: Cellular and Molecular Mechanisms, Prevention, Treatment (Gallo, L.L., ed.), pp. 255-267, Plenum Press
16. Mousa, S. et al. (1993) Cardiology 83, 367-373
17. EPIC Investigators (1994) New Engl. J. Med. 330, 956-961
18. Tcheng, J.E. et al. (1995) Circulation 91, 215-217
19. Peerlinck, K. et al. (1993) Circulation 88 (4 Pt 1), 1512-1517
20. Théroux, P. et al. (1994) Circulation 90, I-232
21. Dondana, P. et al. (1996) Thromb. Res. 82, 163-175
22. Mousa, S. et al. (1994) Life Sci. 54, 1155-1162
23. Mousa, S. et al. (1994) Circulation 89, 3-12
24. Pytela, R. et al. (1986) Science 231, 1559-1562
25. Philips, D.R., Charo, I.F. and Scarborough, R.M. (1991) Cell 65, 359-362
26. D'Souza, S.E. et al. (1990) Biol. Chem. 265, 3440-3446
27. Pedicord, D. et al. (1998) Thromb. Res. 90, 247-258
28. Bednar, R.A. et al. (1998) J. Pharmacol. Exp. Ther. 285, 1317-1326
29. Mousa, S. et al. (1993) Cardiology 83, 374-382
30. Jackson, S. et al. (1994) J. Am. Chem. Soc. 116, 3220-3230
31. Rote, W. et al. (1993) J. Cardiovasc. Pharmacol. 23, 203-211
32. Rote, W. et al. (1993) J. Cardiovasc. Pharmacol. 23, 194-202
33. Mousa, S.A. and Topol, E. (1997) in Current Review of Interventional Cardiology (Vol. 13, 3rd edn) (Serruys, P.W. and Holmes, D., eds), pp. 114-129, Current Medicine
34. Tcheng, J.E. et al. (1994) Circulation 90, 1757-1764
35. Kleiman, N.S. et al. (1993) J. Am. Coll. Cardiol. 22, 381-389
36. Kottke-Marchant, K. et al. (1995) Circulation 92 (8 Suppl.), I-488
37. Cannon, C.P. et al. (1998) Circulation 97, 340-349
38. Newby, L.K. (1999) Am. Heart J. 138, 210-218
39. Muller, T.H. et al. (1997) Circulation 96, 1130-1138
40. Mousa, S.A. and Wityak, J. (1998) Cardiovasc. Drug Rev. 16, 48-61
41. Harrington, R.A. et al. (1998) Circulation 98 (17 Suppl.), I-251
42. Vorchheimer, D.A. and Fuster, V. (1998) Circulation 97, 312-314
43. Quinn, M. and Fitzgerald, D.J. (1998) Am. Heart J. 135 (5 Pt 2), S113-S118